By Dr. Christopher R.D. Menke, DPM, FACFAS — Double Board-Certified Foot & Ankle Surgeon, Founder of 26 Apothecary
This content is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Reading this content does not create a physician-patient relationship between you and Dr. Menke or any healthcare provider affiliated with 26 Apothecary. Individual foot and ankle conditions vary significantly. Consult a qualified healthcare provider for evaluation and treatment of your specific condition.
Toenail Fungus: A Foot Surgeon’s Complete Treatment and Prevention Guide
I see toenail fungus in people who have had it for 10, 15, and 20 years. They watched it start in one nail, spread slowly to adjacent nails, and never treated it because they assumed it was cosmetic. For most of these people, the infection is now moderate to severe, affecting multiple nails with significant structural distortion, and the treatment options are more involved than they would have been at early presentation. Early-stage onychomycosis treated promptly is one of the most manageable nail conditions in podiatric practice. Late-stage onychomycosis is among the most stubborn.
Dr. Christopher R.D. Menke, DPM, FACFAS — double board-certified in foot surgery and rearfoot and ankle reconstruction, founder of 26 Apothecary — provides a complete clinical guide to toenail fungal infection.
What Onychomycosis Actually Is
What is toenail fungus?
Onychomycosis is a fungal infection of the nail plate, nail bed, and in advanced cases, the nail matrix. It is caused in approximately 90% of cases by dermatophytes — most commonly Trichophyton rubrum. The infection enters through micro-separations at the distal or lateral nail edge and progresses proximally toward the nail matrix over months to years. Risk factors include advanced age, diabetes, peripheral artery disease, immunocompromise, nail trauma, occlusive footwear, and exposure to shared moist environments.
The Treatment Spectrum: Matching Intervention to Severity
Mild onychomycosis — distal nail discoloration affecting less than 25% of the nail surface, no matrix involvement — responds to topical antifungal therapy applied consistently over 6 to 12 months. Topical therapy requires extreme consistency — daily application, nail surface preparation, and avoidance of nail polish that impedes penetration.
Moderate onychomycosis — 25 to 75% nail surface involvement, some nail thickening, no matrix involvement — has lower topical clearance rates and benefits from oral antifungal therapy (most commonly terbinafine, 250 mg daily for 12 weeks) under physician supervision.
Severe onychomycosis — more than 75% nail involvement, significant thickening, dystrophy, or matrix involvement — has the lowest clearance rates with any single modality and often requires combination therapy. Laser therapy combined with topical antifungal treatment, or oral antifungal therapy combined with mechanical nail reduction, are standard approaches for advanced cases in podiatric practice.
The Most Common Reason Treatment Fails
Inconsistency. Topical antifungal therapy requires daily application without gaps over 6 to 12 months. People who apply the treatment 3 to 4 times per week, or who stop at the first sign of improvement rather than completing the full course, predictably experience recurrence. Fungal clearance of the nail plate does not mean clearance of the nail bed and matrix — the infection can persist in deeper tissue long after the nail looks improved on the surface.
Preventing Recurrence After Clearance
Rotate footwear to allow shoes to dry completely between uses. Antifungal powder or spray applied to footwear interiors reduces residual fungal load. Moisture-wicking socks replace cotton socks that retain moisture against the skin. Protective footwear in shared wet environments prevents environmental reacquisition. People who have experienced onychomycosis are at elevated risk for recurrence throughout their lifetime and should maintain preventive practices indefinitely.
When to See a Foot and Ankle Specialist
- Any toenail fungal infection in a person with diabetes, peripheral artery disease, or immunocompromise
- Moderate to severe onychomycosis — the clearance rates of topical therapy alone are insufficient at this severity and physician-guided treatment is warranted
- Nail conditions where the diagnosis is uncertain — nail changes can also indicate psoriatic nail disease, trauma, and other conditions that are not fungal in origin
Frequently Asked Questions
Is toenail fungus contagious?
Yes — dermatophytes transmit through direct contact with contaminated skin, nail tissue, or environmental surfaces. Treating all affected individuals in a household simultaneously and disinfecting shared surfaces reduces transmission within the family unit.
Can I just cut off the affected nail?
Removal of the infected nail plate without antifungal treatment does not clear the infection — the fungus resides in the nail bed and matrix, which persist after nail plate removal. Antifungal treatment is required regardless of whether the nail plate is removed.
How long does it take for a cleared nail to look normal?
The great toenail grows approximately 1.5 mm per month — a full nail cycle takes 12 to 18 months. Even after the fungal infection is cleared, the nail plate that grew during the infection period remains dystrophic until it grows out and is replaced by new, healthy nail from the cleared matrix. Setting realistic expectations for cosmetic recovery — 12 to 18 months post-clearance — prevents premature discontinuation of treatment when the nail does not immediately look normal.
About the Author
Dr. Christopher R.D. Menke, DPM, FACFAS is a double board-certified foot and ankle surgeon — board-certified in both foot surgery and rearfoot and ankle reconstruction. He completed his podiatric medical training at Temple University School of Podiatric Medicine in 2005 and his residency at Northlake Medical Center and DeKalb Medical in Georgia, completing in 2008. He is the founder of 26 Foot and Ankle and 26 Apothecary, and the founder of Surgeons of Service, a Georgia-based humanitarian surgical nonprofit. Every product in the 26 Apothecary catalog was selected through the same clinical lens Dr. Menke applies in the exam room and the operating room.
Disclosure: I am the founder and owner of 26 Apothecary. When I reference products available on this site, I have a financial interest in those recommendations. Products are physician-curated based on my clinical experience; that relationship should be understood when considering my product commentary.